Clinical Trial Update: RT+ Anti-PD-1 for Patients With Advanced HCC (RT+PD-1-HCC) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of RT plus anti-PD-1 therapy for hepatocellular carcinoma is underway; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Guangxi Medical University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN